Peter Meiser
Impact in
- Pharmacology top 2%
- Microbial Natural Products and Biosynthesis
- Biotechnology top 5%
- Marine Sponges and Natural Products
Papers in
-
- Phytochemicals and Antioxidant Activities 4
- Co-authors
- Rolf Müller (10 shared papers)Helge B. Bode (4 shared papers)Daniel Krug (3 shared papers)Taifo Mahmud (2 shared papers)Josef Zapp (1 shared paper)Shwan Rachid (1 shared paper)Ekkehard Fluck (3 shared papers)Silke C. Wenzel (1 shared paper)
- Journals
- ChemBioChem (4 papers)Phytotherapy Research (2 papers)Journal of Pharmaceutical and Biomedical Analysis (1 paper)Biotechnology Progress (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- GermanyFranceUnited States
In The Last Decade
Peter Meiser
35 papers receiving 804 citations
Peers
Comparison fields: 5 of 106
- Pharmacology 386
- Biotechnology 179
- Biochemistry 60
- Molecular Biology 466
- Organic Chemistry 157
Countries citing papers authored by Peter Meiser
This map shows the geographic impact of Peter Meiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Meiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Meiser more than expected).
Fields of papers citing papers by Peter Meiser
This network shows the impact of papers produced by Peter Meiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Meiser. The network helps show where Peter Meiser may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Meiser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 137 | |
| 2 | 2006 | 101 | |
| 3 | 2006 | 90 | |
| 4 | 2008 | 66 | |
| 5 | 2015 | 55 | |
| 6 | 2012 | 46 | |
| 7 | 2012 | 43 | |
| 8 | 2011 | 34 | |
| 9 | 2007 | 33 | |
| 10 | 2017 | 26 | |
| 11 | 2020 | 25 | |
| 12 | 2016 | 25 | |
| 13 | 2008 | 24 | |
| 14 | 1971 | 22 | |
| 15 | 1973 | 16 | |
| 16 | 2014 | 12 | |
| 17 | 2013 | 11 | |
| 18 | 1971 | 8 | |
| 19 | 2016 | 8 | |
| 20 | 2014 | 8 |
About Peter Meiser
Peter Meiser is a scholar working on Biochemistry, Organic Chemistry, Pharmacology, Molecular Biology and Biotechnology, having authored 35 papers that have together received 853 indexed citations. Recurring topics across this work include Pineapple and bromelain studies (7 papers), Microbial Natural Products and Biosynthesis (6 papers), Biochemical and Structural Characterization (6 papers), Phytochemicals and Antioxidant Activities (4 papers), COVID-19 Clinical Research Studies (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Marine Sponges and Natural Products (3 papers). The work is most often cited by research in Pharmacology (386 citations), Biotechnology (179 citations), Biochemistry (60 citations), Molecular Biology (466 citations) and Organic Chemistry (157 citations). Peter Meiser has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Rolf Müller, Helge B. Bode, Daniel Krug, Taifo Mahmud, Josef Zapp, Shwan Rachid, Ekkehard Fluck, Silke C. Wenzel, Tina M. Binz and Kira J. Weissman. Their work appears in journals such as ChemBioChem, Phytotherapy Research, Journal of Pharmaceutical and Biomedical Analysis, Biotechnology Progress and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.